Mark E. Robson
Memorial Sloan Kettering Cancer Center(US)Kettering University(US)Culham Science Centre(GB)United Kingdom Atomic Energy Authority(GB)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, PARP inhibition in cancer therapy, DNA Repair Mechanisms
Most-Cited Works
- → Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients(2017)3,455 cited
- → Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation(2017)3,123 cited
- → Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer(2016)1,630 cited
- → Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial(2010)1,629 cited
- → ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer(2021)1,286 cited
- → Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation(2002)1,251 cited